Olga Brawman-Mintzer

Title
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
AddressP.O. Box MSC 861
5900 Core Rd. Suite 203, N Charleston, SC
Phone843-740-1592
Fax843-740-6113
vCardDownload vCard

    Collapse Overview 
    Collapse keywords
    Drug Studies, Mental Health, Depression

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Mintzer J, Lanctôt KL, Scherer RW, Rosenberg PB, Herrmann N, van Dyck CH, Padala PR, Brawman-Mintzer O, Porsteinsson AP, Lerner AJ, Craft S, Levey AI, Burke W, Perin J, Shade D, Mintzer J, Lanct?t KL, Scherer RW, Rosenberg PB, Herrmann N, van Dyck CH, Padala PR, Brawman-Mintzer O, Porsteinsson AP, Lerner AJ, Craft S, Levey AI, Burke W, Perin J, Shade D, ADMET 2 Research Group. Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial. JAMA Neurol. 2021 11 01; 78(11):1324-1332. PMID: 34570180; PMCID: PMC8477302.
      Citations:    
    2. Brawman-Mintzer O, Tang XC, Bizien M, Harvey PD, Horner MD, Arciniegas DB, Raskind M, Johnson-Greene L, Martineau RJ, Hamner M, Rodriguez-Suarez M, Jorge RE, McGarity S, Wortzel HS, Wei Y, Sindowski T, Mintzer J, Kindy AZ, Donovan K, Reda D, Brawman-Mintzer O, Tang XC, Bizien M, Harvey PD, Horner MD, Arciniegas DB, Raskind M, Johnson-Greene L, Martineau RJ, Hamner M, Rodriguez-Suarez M, Jorge RE, McGarity S, Wortzel HS, Wei Y, Sindowski T, Mintzer J, Kindy AZ, Donovan K, Reda D. Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical Trial. J Neurotrauma. 2021 07 15; 38(14):1943-1952. PMID: 33514274.
      Citations:    
    3. Lanctôt KL, Scherer RW, Li A, Vieira D, Coulibaly H, Rosenberg PB, Herrmann N, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer JE, Lanct?t KL, Scherer RW, Li A, Vieira D, Coulibaly H, Rosenberg PB, Herrmann N, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer JE. Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments. Am J Geriatr Psychiatry. 2021 01; 29(1):81-89. PMID: 32565008; PMCID: PMC7704818.
      Citations:    
    4. van Dyck CH, Arnsten AFT, Padala PR, Brawman-Mintzer O, Lerner AJ, Porsteinsson AP, Scherer RW, Levey AI, Herrmann N, Jamil N, Mintzer JE, Lanctôt KL, Rosenberg PB, van Dyck CH, Arnsten AFT, Padala PR, Brawman-Mintzer O, Lerner AJ, Porsteinsson AP, Scherer RW, Levey AI, Herrmann N, Jamil N, Mintzer JE, Lanct?t KL, Rosenberg PB. Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate. Am J Geriatr Psychiatry. 2021 01; 29(1):51-62. PMID: 32461027; PMCID: PMC7641967.
      Citations:    
    5. Richards C, Iosifescu DV, Mago R, Sarkis E, Geibel B, Dauphin M, McIntyre RS, Weisler R, Brawman-Mintzer O, Gu J, Madhoo M, Richards C, Iosifescu DV, Mago R, Sarkis E, Geibel B, Dauphin M, McIntyre RS, Weisler R, Brawman-Mintzer O, Gu J, Madhoo M. A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults. J Clin Psychopharmacol. 2018 Aug; 38(4):336-343. PMID: 29912786; PMCID: PMC6039401.
      Citations:    
    6. Scherer RW, Drye L, Mintzer J, Lanctôt K, Rosenberg P, Herrmann N, Padala P, Brawman-Mintzer O, Burke W, Craft S, Lerner AJ, Levey A, Porsteinsson A, van Dyck CH, Scherer RW, Drye L, Mintzer J, Lanct?t K, Rosenberg P, Herrmann N, Padala P, Brawman-Mintzer O, Burke W, Craft S, Lerner AJ, Levey A, Porsteinsson A, van Dyck CH, ADMET 2 Research Group. The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial. Trials. 2018 Jan 18; 19(1):46. PMID: 29347996; PMCID: PMC5774109.
      Citations:    
    7. Richards C, McIntyre RS, Weisler R, Sambunaris A, Brawman-Mintzer O, Gao J, Geibel B, Dauphin M, Madhoo M, Richards C, McIntyre RS, Weisler R, Sambunaris A, Brawman-Mintzer O, Gao J, Geibel B, Dauphin M, Madhoo M. Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies. J Affect Disord. 2016 Dec; 206:151-160. PMID: 27474961.
      Citations:    
    8. Pauls Q, Durkalski-Mauldin V, Brawman-Mintzer O, Lawrence C, Whichard R, Cotton PB, Pauls Q, Durkalski-Mauldin V, Brawman-Mintzer O, Lawrence C, Whichard R, Cotton PB. Duloxetine for the Treatment of Patients with Suspected Sphincter of Oddi Dysfunction: A Pilot Study. Dig Dis Sci. 2016 09; 61(9):2704-9. PMID: 27165434.
      Citations:    
    9. Orr RK, Hoehn JL, Col NF, Hershenberg R, Gros DF, Brawman-Mintzer O. Role of atypical antipsychotics in the treatment of generalized anxiety disorder. CNS Drugs. 2014 Jun; 28(6):519-33. PMID: 24794100.
      Citations:    
    10. Cotton PB, Durkalski V, Romagnuolo J, Pauls Q, Fogel E, Tarnasky P, Aliperti G, Freeman M, Kozarek R, Jamidar P, Wilcox M, Serrano J, Brawman-Mintzer O, Elta G, Mauldin P, Thornhill A, Hawes R, Wood-Williams A, Orrell K, Drossman D, Robuck P, Cotton PB, Durkalski V, Romagnuolo J, Pauls Q, Fogel E, Tarnasky P, Aliperti G, Freeman M, Kozarek R, Jamidar P, Wilcox M, Serrano J, Brawman-Mintzer O, Elta G, Mauldin P, Thornhill A, Hawes R, Wood-Williams A, Orrell K, Drossman D, Robuck P. Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial. JAMA. 2014 May; 311(20):2101-9. PMID: 24867013; PMCID: PMC4428324.
      Citations:    
    11. Romagnuolo J, Cotton PB, Durkalski V, Pauls Q, Brawman-Mintzer O, Drossman DA, Mauldin P, Orrell K, Williams AW, Fogel EL, Tarnasky PR, Aliperti G, Freeman ML, Kozarek RA, Jamidar PA, Wilcox CM, Serrano J, Elta GH, Romagnuolo J, Cotton PB, Durkalski V, Pauls Q, Brawman-Mintzer O, Drossman DA, Mauldin P, Orrell K, Williams AW, Fogel EL, Tarnasky PR, Aliperti G, Freeman ML, Kozarek RA, Jamidar PA, Wilcox CM, Serrano J, Elta GH. Can patient and pain characteristics predict manometric sphincter of Oddi dysfunction in patients with clinically suspected sphincter of Oddi dysfunction? Gastrointest Endosc. 2014 May; 79(5):765-72. PMID: 24472759; PMCID: PMC4409681.
      Citations:    
    12. Brawman-Mintzer O, Durkalski V, Wu Q, Romagnuolo J, Fogel E, Tarnasky P, Aliperti G, Freeman M, Kozarek R, Jamidar P, Wilcox M, Elta G, Orrell K, Wood A, Mauldin P, Serrano J, Drossman D, Robuck P, Cotton P, Brawman-Mintzer O, Durkalski V, Wu Q, Romagnuolo J, Fogel E, Tarnasky P, Aliperti G, Freeman M, Kozarek R, Jamidar P, Wilcox M, Elta G, Orrell K, Wood A, Mauldin P, Serrano J, Drossman D, Robuck P, Cotton P. Psychosocial characteristics and pain burden of patients with suspected sphincter of Oddi dysfunction in the EPISOD multicenter trial. Am J Gastroenterol. 2014 Mar; 109(3):436-42. PMID: 24445573; PMCID: PMC4409683.
      Citations:    
    13. Milanak ME, Gros DF, Magruder KM, Brawman-Mintzer O, Frueh BC, Milanak ME, Gros DF, Magruder KM, Brawman-Mintzer O, Frueh BC. Prevalence and features of generalized anxiety disorder in Department of Veteran Affairs primary care settings. Psychiatry Res. 2013 Sep 30; 209(2):173-9. PMID: 23659756; PMCID: PMC4026032.
      Citations:    
    14. Horner MD, Mintzer JE, Turner TH, Edmiston KR, Brawman-Mintzer O, Horner MD, Mintzer JE, Turner TH, Edmiston KR, Brawman-Mintzer O. Attentional functioning in patients with posttraumatic stress disorder: a preliminary study. CNS Spectr. 2013 Apr; 18(2):90-4. PMID: 23298713.
      Citations:    
    15. Magruder KM, Yeager D, Brawman-Mintzer O, Magruder KM, Yeager D, Brawman-Mintzer O. The role of pain, functioning, and mental health in suicidality among Veterans Affairs primary care patients. Am J Public Health. 2012 Mar; 102 Suppl 1:S118-24. PMID: 22390584; PMCID: PMC3496452.
      Citations:    
    16. Katzman MA, Brawman-Mintzer O, Reyes EB, Olausson B, Liu S, Eriksson H, Katzman MA, Brawman-Mintzer O, Reyes EB, Olausson B, Liu S, Eriksson H. Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial. Int Clin Psychopharmacol. 2011 Jan; 26(1):11-24. PMID: 20881846.
      Citations:    
    17. Cotton PB, Durkalski V, Orrell KB, Brawman-Mintzer O, Drossman DA, Wilcox CM, Mauldin PD, Elta GH, Tarnasky PR, Fogel EL, Jagganath SB, Kozarek RA, Freeman ML, Romagnuolo J, Robuck PR, Cotton PB, Durkalski V, Orrell KB, Brawman-Mintzer O, Drossman DA, Wilcox CM, Mauldin PD, Elta GH, Tarnasky PR, Fogel EL, Jagganath SB, Kozarek RA, Freeman ML, Romagnuolo J, Robuck PR. Challenges in planning and initiating a randomized clinical study of sphincter of Oddi dysfunction. Gastrointest Endosc. 2010 Nov; 72(5):986-91. PMID: 21034899; PMCID: PMC4409682.
      Citations:    
    18. Orr RK, Hoehn JL, Col NF, Stein MB, Ravindran LN, Simon NM, Liebowitz MR, Khan A, Brawman-Mintzer O, Lydiard RB, Pollack MH. Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial. J Clin Psychiatry. 2010 May; 71(5):627-31. PMID: 20021997.
      Citations:    
    19. Russell J, Raskin J, Wiltse C, Walker D, Brawman-Mintzer O, Russell J, Raskin J, Wiltse C, Walker D, Brawman-Mintzer O. Efficacy and tolerability of duloxetine treatment in elderly patients with major depressive disorder and concurrent anxiety symptoms. Psychiatry (Edgmont). 2007 Jun; 4(6):33-45. PMID: 20711334; PMCID: PMC2921247.
      Citations:    
    20. Brawman-Mintzer O, Knapp RG, Rynn M, Carter RE, Rickels K, Brawman-Mintzer O, Knapp RG, Rynn M, Carter RE, Rickels K. Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2006 Jun; 67(6):874-81. PMID: 16848646.
      Citations:    
    21. Brawman-Mintzer O, Knapp RG, Nietert PJ, Brawman-Mintzer O, Knapp RG, Nietert PJ. Adjunctive risperidone in generalized anxiety disorder: a double-blind, placebo-controlled study. J Clin Psychiatry. 2005 Oct; 66(10):1321-5. PMID: 16259547.
      Citations:    
    22. Brawman-Mintzer O, Monnier J, Wolitzky KB, Falsetti SA, Brawman-Mintzer O, Monnier J, Wolitzky KB, Falsetti SA. Patients with generalized anxiety disorder and a history of trauma: somatic symptom endorsement. J Psychiatr Pract. 2005 May; 11(3):212-5. PMID: 15920396.
      Citations:    
    23. Rynn MA, Brawman-Mintzer O, Rynn MA, Brawman-Mintzer O. Generalized anxiety disorder: acute and chronic treatment. CNS Spectr. 2004 Oct; 9(10):716-23. PMID: 15448583.
      Citations:    
    24. Brawman-Mintzer O, Yonkers KA, Brawman-Mintzer O, Yonkers KA. New trends in the treatment of anxiety disorders. CNS Spectr. 2004 Aug; 9(8 Suppl 7):19-27. PMID: 15303077.
      Citations:    
    25. Yonkers KA, Brawman-Mintzer O, Yonkers KA, Brawman-Mintzer O. The pharmacologic treatment of depression: is gender a critical factor? J Clin Psychiatry. 2002 Jul; 63(7):610-5. PMID: 12143920.
      Citations: 7     Fields:    Translation:Humans
    26. Brawman-Mintzer O, Brawman-Mintzer O. Pharmacologic treatment of generalized anxiety disorder. Psychiatr Clin North Am. 2001 Mar; 24(1):119-37. PMID: 11225503.
      Citations: 5     Fields:    Translation:Humans
    27. Howell HB, Brawman-Mintzer O, Monnier J, Yonkers KA, Howell HB, Brawman-Mintzer O, Monnier J, Yonkers KA. Generalized anxiety disorder in women. Psychiatr Clin North Am. 2001 Mar; 24(1):165-78. PMID: 11225506.
      Citations: 11     Fields:    Translation:Humans
    28. Emmanuel NP, Brawman-Mintzer O, Morton WA, Book SW, Johnson MR, Lorberbaum JP, Ballenger JC, Lydiard RB, Emmanuel NP, Brawman-Mintzer O, Morton WA, Book SW, Johnson MR, Lorberbaum JP, Ballenger JC, Lydiard RB. Bupropion-SR in treatment of social phobia. Depress Anxiety. 2000; 12(2):111-3. PMID: 11091936.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    29. DeVane CL, Ware MR, Emmanuel NP, Brawman-Mintzer O, Morton WA, Villarreal G, Lydiard RB, DeVane CL, Ware MR, Emmanuel NP, Brawman-Mintzer O, Morton WA, Villarreal G, Lydiard RB. Evaluation of the efficacy, safety and physiological effects of fluvoxamine in social phobia. Int Clin Psychopharmacol. 1999 Nov; 14(6):345-51. PMID: 10565801.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    30. Emmanuel NP, Ware MR, Brawman-Mintzer O, Ballenger JC, Lydiard RB, Emmanuel NP, Ware MR, Brawman-Mintzer O, Ballenger JC, Lydiard RB. Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder. J Clin Psychiatry. 1999 May; 60(5):299-301. PMID: 10362436.
      Citations: 3     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    31. Lorberbaum JP, Newman JD, Dubno JR, Horwitz AR, Nahas Z, Teneback CC, Bloomer CW, Bohning DE, Vincent D, Johnson MR, Emmanuel N, Brawman-Mintzer O, Book SW, Lydiard RB, Ballenger JC, George MS, Lorberbaum JP, Newman JD, Dubno JR, Horwitz AR, Nahas Z, Teneback CC, Bloomer CW, Bohning DE, Vincent D, Johnson MR, Emmanuel N, Brawman-Mintzer O, Book SW, Lydiard RB, Ballenger JC, George MS. Feasibility of using fMRI to study mothers responding to infant cries. Depress Anxiety. 1999; 10(3):99-104. PMID: 10604082.
      Citations: 34     Fields:    Translation:Humans
    32. Mintzer J, Brawman-Mintzer O, Mirski DF, Unger R, Nietert P, Meeks A, Sampson R, Mintzer J, Brawman-Mintzer O, Mirski DF, Unger R, Nietert P, Meeks A, Sampson R. Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia and agitation. Biol Psychiatry. 1998 Nov 01; 44(9):918-21. PMID: 9807649.
      Citations: 6     Fields:    Translation:Humans
    33. Labbate LA, Johnson MR, Lydiard RB, Brawman-Mintzer O, Emmanuel N, Crawford M, Kapp R, Ballenger JC, Labbate LA, Johnson MR, Lydiard RB, Brawman-Mintzer O, Emmanuel N, Crawford M, Kapp R, Ballenger JC. Sleep Deprivation in social phobia and generalized anxiety disorder. Biol Psychiatry. 1998 Jun 01; 43(11):840-2. PMID: 9611674.
      Citations: 5     Fields:    Translation:Humans
    34. Johnson MR, Marazziti D, Brawman-Mintzer O, Emmanuel NP, Ware MR, Morton WA, Rossi A, Cassano GB, Lydiard RB, Johnson MR, Marazziti D, Brawman-Mintzer O, Emmanuel NP, Ware MR, Morton WA, Rossi A, Cassano GB, Lydiard RB. Abnormal peripheral benzodiazepine receptor density associated with generalized social phobia. Biol Psychiatry. 1998 Feb 15; 43(4):306-9. PMID: 9513742.
      Citations: 7     Fields:    Translation:HumansCellsCTClinical Trials
    35. Lydiard RB, Brawman-Mintzer O, Lydiard RB, Brawman-Mintzer O. Anxious depression. J Clin Psychiatry. 1998; 59 Suppl 18:10-7. PMID: 9840193.
      Citations: 10     Fields:    Translation:Humans
    36. Labbate LA, Johnson MR, Lydiard RB, Brawman-Mintzer O, Emmanuel N, Crawford M, Kapp R, Ballenger JC, Labbate LA, Johnson MR, Lydiard RB, Brawman-Mintzer O, Emmanuel N, Crawford M, Kapp R, Ballenger JC. Sleep deprivation in panic disorder and obsessive-compulsive disorder. Can J Psychiatry. 1997 Nov; 42(9):982-3. PMID: 9429072.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    37. Brawman-Mintzer O, Lydiard RB, Bradwejn J, Villarreal G, Knapp R, Emmanuel N, Ware MR, He Q, Ballenger JC, Brawman-Mintzer O, Lydiard RB, Bradwejn J, Villarreal G, Knapp R, Emmanuel N, Ware MR, He Q, Ballenger JC. Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder. Am J Psychiatry. 1997 May; 154(5):700-2. PMID: 9137133.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    38. Brawman-Mintzer O, Lydiard RB, Brawman-Mintzer O, Lydiard RB. Biological basis of generalized anxiety disorder. J Clin Psychiatry. 1997; 58 Suppl 3:16-25; discussion 26. PMID: 9133489.
      Citations: 7     Fields:    Translation:Humans
    39. Lydiard RB, Brawman-Mintzer O, Lydiard RB, Brawman-Mintzer O. Panic disorder across the life span: a differential diagnostic approach to treatment resistance. Bull Menninger Clin. 1997; 61(2 Suppl A):A66-94. PMID: 9149466.
      Citations: 1     Fields:    Translation:Humans
    40. Lydiard RB, Brawman-Mintzer O, Ballenger JC, Lydiard RB, Brawman-Mintzer O, Ballenger JC. Recent developments in the psychopharmacology of anxiety disorders. J Consult Clin Psychol. 1996 Aug; 64(4):660-8. PMID: 8803355.
      Citations: 7     Fields:    Translation:Humans
    41. Brawman-Mintzer O, Lydiard RB, Brawman-Mintzer O, Lydiard RB. Generalized anxiety disorder: issues in epidemiology. J Clin Psychiatry. 1996; 57 Suppl 7:3-8. PMID: 8690694.
      Citations: 3     Fields:    Translation:Humans
    42. Mintzer JE, Brawman-Mintzer O, Mintzer JE, Brawman-Mintzer O. Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach. J Clin Psychiatry. 1996; 57 Suppl 7:55-63; discussion 73-5. PMID: 8690698.
      Citations: 9     Fields:    Translation:Humans
    43. Brawman-Mintzer O, Lydiard RB, Phillips KA, Morton A, Czepowicz V, Emmanuel N, Villareal G, Johnson M, Ballenger JC, Brawman-Mintzer O, Lydiard RB, Phillips KA, Morton A, Czepowicz V, Emmanuel N, Villareal G, Johnson M, Ballenger JC. Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study. Am J Psychiatry. 1995 Nov; 152(11):1665-7. PMID: 7485632.
      Citations: 16     Fields:    Translation:Humans
    44. Brawman-Mintzer O, Lydiard RB, Crawford MM, Emmanuel N, Payeur R, Johnson M, Knapp RG, Ballenger JC, Brawman-Mintzer O, Lydiard RB, Crawford MM, Emmanuel N, Payeur R, Johnson M, Knapp RG, Ballenger JC. Somatic symptoms in generalized anxiety disorder with and without comorbid psychiatric disorders. Am J Psychiatry. 1994 Jun; 151(6):930-2. PMID: 8185009.
      Citations: 3     Fields:    Translation:Humans
    45. Brawman-Mintzer O, Lydiard RB, Emmanuel N, Payeur R, Johnson M, Roberts J, Jarrell MP, Ballenger JC, Brawman-Mintzer O, Lydiard RB, Emmanuel N, Payeur R, Johnson M, Roberts J, Jarrell MP, Ballenger JC. Psychiatric comorbidity in patients with generalized anxiety disorder. Am J Psychiatry. 1993 Aug; 150(8):1216-8. PMID: 8328567.
      Citations: 14     Fields:    Translation:Humans
    46. Mellman TA, Randolph CA, Brawman-Mintzer O, Flores LP, Milanes FJ, Mellman TA, Randolph CA, Brawman-Mintzer O, Flores LP, Milanes FJ. Phenomenology and course of psychiatric disorders associated with combat-related posttraumatic stress disorder. Am J Psychiatry. 1992 Nov; 149(11):1568-74. PMID: 1415826.
      Citations: 15     Fields:    Translation:HumansAnimals
    47. Brawman-Mintzer O, Mondino BJ, Mayer FJ, Brawman-Mintzer O, Mondino BJ, Mayer FJ. Distribution of complement in the sclera. Invest Ophthalmol Vis Sci. 1989 Oct; 30(10):2240-4. PMID: 2793362.
      Citations: 1     Fields:    Translation:Humans
    48. Brawman-Mintzer O, Mondino BJ, Mayer FJ, Brawman-Mintzer O, Mondino BJ, Mayer FJ. The complement system in sclera. Invest Ophthalmol Vis Sci. 1988 Nov; 29(11):1756-8. PMID: 3182209.
      Citations: 1     Fields:    Translation:Humans
    49. Mondino BJ, Brawman-Mintzer O, Boothe WA, Mondino BJ, Brawman-Mintzer O, Boothe WA. Immunological complications of soft contact lenses. J Am Optom Assoc. 1987 Oct; 58(10):832-5. PMID: 3316352.
      Citations: 1     Fields:    Translation:Humans
    50. Mondino BJ, Brawman-Mintzer O, Adamu SA, Mondino BJ, Brawman-Mintzer O, Adamu SA. Corneal antibody levels to ribitol teichoic acid in rabbits immunized with staphylococcal antigens using various routes. Invest Ophthalmol Vis Sci. 1987 Sep; 28(9):1553-8. PMID: 3623839.
      Citations: 2     Fields:    Translation:AnimalsCellsPHPublic Health
    Brawman-Mintzer's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (212)
    Explore
    _
    Co-Authors (20)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _